Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial

ConclusionPatients ’ adherence to treatment was low. With this limitation, the combined choline alphoscerate–nimodipine treatment showed no significant effect in our cohort of VCI patients with SVD. The safety profile was good overall.Trial RegistrationClinical Trial NCT03228498. Registered 25 July 2017.
Source: Drugs and Aging - Category: Geriatrics Source Type: research